"Henry Ford Medical Center – Fairlane offers many specialty services, including allergy, audiology, cancer care, cosmetic and plastic surgery, ENT, rehabilitation services, orthopedics, urology, and vascular surgery. Other on-site services include laboratory, pharmacy and radiology. There also is a Walk-In Clinic for non-emergency medical concerns like fever, eye infections, rashes, cough, deep cuts and fractures."

During the past decade, Henry Ford Medical Center-Fairlane conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 22 clinical trials were completed, i.e. on average, 29.3% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 19 clinical trials were completed. i.e. 67.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Henry Ford Medical Center-Fairlane" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "NRG Oncology" with 8 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Medical Center-Fairlane" #1 collaborator was "National Cancer Institute (NCI)" with 40 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Henry Ford Medical Center-Fairlane" are "Chronic Lymphocytic Leukemia" (4 trials), "Invasive Breast Carcinoma" (4 trials), "Recurrent Breast Carcinoma" (4 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Recurrent Squamous Cell Lung Carcinoma" (4 trials). Many other conditions were trialed in "Henry Ford Medical Center-Fairlane" in a lesser frequency.

Most popular intervention types in "Henry Ford Medical Center-Fairlane" are "Drug" (74 trials), "Other" (50 trials), "Biological" (41 trials), "Procedure" (27 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (23 trials), "Biospecimen Collection" (19 trials), "Computed Tomography" (17 trials) and "Nivolumab" (16 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Medical Center-Fairlane" are 78 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Henry Ford Medical Center-Fairlane". undefined are not yet recruiting, 27 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Henry Ford Medical Center-Fairlane, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Medical Center-Fairlane, 3 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".